[go: up one dir, main page]

CN101875681B - Synthetic method of 16alpha-hydroxy prednisonlone - Google Patents

Synthetic method of 16alpha-hydroxy prednisonlone Download PDF

Info

Publication number
CN101875681B
CN101875681B CN2010102058780A CN201010205878A CN101875681B CN 101875681 B CN101875681 B CN 101875681B CN 2010102058780 A CN2010102058780 A CN 2010102058780A CN 201010205878 A CN201010205878 A CN 201010205878A CN 101875681 B CN101875681 B CN 101875681B
Authority
CN
China
Prior art keywords
reaction
prednisolone
synthetic method
hydroxyprednisolone
hydrogen peroxide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2010102058780A
Other languages
Chinese (zh)
Other versions
CN101875681A (en
Inventor
裴文
孙莉
王海滨
郑洁
潘海燕
胡香凝
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wudi Xinyue Chemical Group Co ltd
Original Assignee
Zhejiang University of Technology ZJUT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhejiang University of Technology ZJUT filed Critical Zhejiang University of Technology ZJUT
Priority to CN2010102058780A priority Critical patent/CN101875681B/en
Publication of CN101875681A publication Critical patent/CN101875681A/en
Application granted granted Critical
Publication of CN101875681B publication Critical patent/CN101875681B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Steroid Compounds (AREA)

Abstract

本发明公开了一种结构如式(Ⅲ)所示的16α-羟基泼尼松龙的合成方法,包括如下步骤:以结构如式(Ⅰ)所示的泼尼松龙为原料,在结构如式(Ⅱ)所示的酸性离子液体中,先进行脱水反应生成双键,然后加入过氧化氢水溶液进行反应,充分反应后加入水进一步水解,最后得到所述的16α-羟基泼尼松龙。本发明所述的合成方法利用酸性离子液体既作为反应介质又作为催化剂的性质,通过改变反应时间和反应温度等工艺条件,实现了降低成本、节能减排的目的,适于工业化生产。

Figure DDA0000022570350000011
The invention discloses a method for synthesizing 16α-hydroxyprednisolone with a structure as shown in formula (III), comprising the following steps: using prednisolone with a structure as shown in formula (I) as a raw material, in the structure as shown in In the acidic ionic liquid shown in formula (II), the dehydration reaction is carried out first to generate double bonds, and then an aqueous hydrogen peroxide solution is added for the reaction. After sufficient reaction, water is added for further hydrolysis, and finally the 16α-hydroxyprednisolone is obtained. The synthetic method of the present invention utilizes the properties of the acidic ionic liquid as both a reaction medium and a catalyst, and realizes the purpose of cost reduction, energy saving and emission reduction by changing process conditions such as reaction time and reaction temperature, and is suitable for industrial production.
Figure DDA0000022570350000011

Description

一种16α-羟基泼尼松龙的合成方法A kind of synthetic method of 16α-hydroxyprednisolone

(一)技术领域 (1) Technical field

本发明涉及一种16α-羟基泼尼松龙的合成方法。The invention relates to a method for synthesizing 16α-hydroxyprednisolone.

(二)背景技术 (2) Background technology

16α-羟基泼尼松龙,化学式:C21H28O6,分子量:376.44。是一种治疗哮喘病的药物-环索奈德的重要中间体。关于16α-羟基泼尼松龙的合成,目前报道的方法都是以泼尼松龙为原料,与原乙酸三乙酯在对甲苯磺酸吡啶盐催化作用下成环,弱酸性条件下选择性开环得乙酰化物,再在碱性条件下与乙酐反应生成二乙酰化物后,醋酸钾存在下加热脱去一分子的醋酸得(11β)-羟基-21-乙酰氧基-1,4,16-孕甾三烯-3,20-二酮化合物。将此化合物在高锰酸钾作用下选择性双羟基化,氢氧化钠的存在下脱乙酰化得产物16α-羟基泼尼松龙。在已有的合成路线中,合成步骤长,产品后处理复杂。16α-Hydroxyprednisolone, chemical formula: C 21 H 28 O 6 , molecular weight: 376.44. It is an important intermediate of ciclesonide, a drug for the treatment of asthma. Regarding the synthesis of 16α-hydroxyprednisolone, the methods reported at present all use prednisolone as a raw material, and form a ring with triethyl orthoacetate under the catalysis of pyridinium p-toluenesulfonate, and selectivity under weakly acidic conditions Ring-opening to obtain acetylated products, and then reacting with acetic anhydride under alkaline conditions to form diacetylated products, heating in the presence of potassium acetate to remove a molecule of acetic acid to obtain (11β)-hydroxy-21-acetoxy-1,4, 16-Pregnatriene-3,20-dione compound. The compound is selectively dihydroxylated under the action of potassium permanganate, and deacetylated in the presence of sodium hydroxide to obtain the product 16α-hydroxyprednisolone. In the existing synthetic routes, the synthetic steps are long and the product post-processing is complicated.

近年来,我们正致力于各类离子液体在激素类药物及中间体合成中的应用研究。离子液体是由有机阳离子和无机或有机阴离子两部分组成、在室温及相邻温度下呈液态的离子体系。离子液体具有许多其它物质无法比拟的优点,如液态温度范围宽,没有显著的蒸汽压,热稳定性好,具有酸性或超强酸性,并且酸性可以根据需要进行调变,对许多无机化合物和有机化合物等具有良好的溶解性,电化学窗口宽、可以克服均相催化剂的分离、回收困难和对环境造成污染,同时兼有均相催化剂高反应活性和多相催化剂易与产物分离的优点。基于这些特点,离子液体在萃取分离、催化反应、电化学等方面有着广泛的应用。酸性离子液体的酸性是由阴离子的本质决定的。酸性离子液体分为“Lewis酸性离子液体”和“Brōnsted酸性离子液体”。酸性离子液体的优点是离子液体作为一种新型环境友好型酸催化剂,具有腐蚀性小;反应条件缓和;酸性可以调节;可以循环使用。克服了传统Lewis酸催化剂带来的环境污染问题,并且在酸催化反应中表现出良好的活性和选择性。有望成为21世纪最有前景的绿色溶剂和催化剂之一。In recent years, we are committed to the application research of various ionic liquids in the synthesis of hormone drugs and intermediates. Ionic liquids are ionic systems composed of organic cations and inorganic or organic anions, which are liquid at room temperature and adjacent temperatures. Ionic liquids have many advantages that other substances cannot match, such as wide liquid temperature range, no significant vapor pressure, good thermal stability, acidic or super acidic, and acidity can be adjusted according to needs, and it is suitable for many inorganic compounds and organic compounds. Compounds have good solubility, wide electrochemical window, can overcome the separation and recovery difficulties of homogeneous catalysts, and cause environmental pollution. At the same time, they have the advantages of high reactivity of homogeneous catalysts and easy separation of heterogeneous catalysts from products. Based on these characteristics, ionic liquids have been widely used in extraction and separation, catalytic reaction, electrochemistry and so on. The acidity of acidic ionic liquids is determined by the nature of the anions. Acidic ionic liquids are divided into "Lewis acidic ionic liquids" and "Brōnsted acidic ionic liquids". The advantages of acidic ionic liquids are that ionic liquids, as a new type of environmentally friendly acid catalyst, are less corrosive; the reaction conditions are mild; the acidity can be adjusted; and they can be recycled. It overcomes the environmental pollution problems caused by traditional Lewis acid catalysts, and exhibits good activity and selectivity in acid-catalyzed reactions. It is expected to become one of the most promising green solvents and catalysts in the 21st century.

(三)发明内容 (3) Contents of the invention

本发明要解决的技术问题在于提供一种利用酸性离子液体同时作为反应介质和催化剂合成16α-羟基泼尼松龙的方法,该技术易操作,产能高,效率好,三废少,后处理方便,离子液体可重复使用,具有经济实用的特点。The technical problem to be solved in the present invention is to provide a method for synthesizing 16α-hydroxyprednisolone by using an acidic ionic liquid simultaneously as a reaction medium and a catalyst. Ionic liquids are reusable, economical and practical.

为解决上述技术问题,本发明采用如下技术方案:In order to solve the problems of the technologies described above, the present invention adopts the following technical solutions:

一种结构如式(III)所示的16α-羟基泼尼松龙的合成方法,包括如下步骤:以结构如式(I)所示的泼尼松龙为原料,在如式(II)所示的酸性离子液体中,先进行脱水反应生成双键,然后加入过氧化氢水溶液进行反应,充分反应后再加入水进一步水解,最后得到所述的16α-羟基泼尼松龙;A kind of synthetic method of the 16 alpha-hydroxy prednisolone shown in formula (III) of structure, comprises the steps: be raw material with the prednisolone shown in formula (I) of structure, in formula (II) In the acidic ionic liquid shown, first carry out dehydration reaction and generate double bond, then add hydrogen peroxide aqueous solution to react, add water after sufficient reaction and further hydrolyze, finally obtain described 16α-hydroxy prednisolone;

式(II)中,R为C1~C10的取代烷基,所述的取代烷基的取代基为磺酸基或羧基,L为HSO4、COO、CH3COO、BF4、PF6或CF3SO3;或者R为C1~C10的烷基,L为HSO4、COO或CF3SO3In formula (II), R is a C1-C10 substituted alkyl group, the substituent of the substituted alkyl group is a sulfonic acid group or a carboxyl group, and L is HSO 4 , COO, CH 3 COO, BF 4 , PF 6 or CF 3 SO 3 ; or R is a C1-C10 alkyl group, and L is HSO 4 , COO or CF 3 SO 3 .

本发明的技术方案中,原料泼尼松龙先脱水生成双键,然后以过氧化氢为氧化剂进行氧化反应,氧化后进行水解反应,最后得到目标产物。In the technical scheme of the present invention, the raw material prednisolone is first dehydrated to form double bonds, then the oxidation reaction is carried out with hydrogen peroxide as the oxidant, and the hydrolysis reaction is carried out after the oxidation to finally obtain the target product.

进一步,所述的式(II)所示的酸性离子液体,优选:R为C1~C10的取代烷基,所述的取代烷基的取代基为磺酸基;更进一步,优选L为HSO4、CH3COO或BF4Further, the acidic ionic liquid represented by the formula (II), preferably: R is a C1-C10 substituted alkyl group, and the substituent of the substituted alkyl group is a sulfonic acid group; furthermore, preferably L is HSO 4 , CH 3 COO or BF 4 .

进一步,所述的脱水反应优选在100~150℃的温度条件下进行,更优选110~130℃。通过TLC跟踪监测反应过程,直至原料点消失,推荐以环己烷∶丙酮(体积比)=5∶5的混合溶剂作为展开剂。Further, the dehydration reaction is preferably carried out at a temperature of 100-150°C, more preferably 110-130°C. Follow and monitor the reaction process by TLC until the raw material point disappears. It is recommended to use a mixed solvent of cyclohexane:acetone (volume ratio)=5:5 as a developing solvent.

进一步,所述的氧化反应和水解反应优选在10~60℃的温度条件下进行,更优选氧化反应和水解反应在40~60℃的温度条件下进行。优选加入过氧化氢水溶液后,反应5~50小时,然后加入水进一步水解;更优选加入过氧化氢水溶液后,反应10~40小时,然后加入水进一步水解。本发明通过TLC跟踪监测上述反应过程,推荐以环己烷∶丙酮(体积比)=5∶5的混合溶剂作为展开剂。Furthermore, the oxidation reaction and hydrolysis reaction are preferably carried out at a temperature of 10-60°C, more preferably the oxidation reaction and hydrolysis reaction are carried out at a temperature of 40-60°C. Preferably after adding aqueous hydrogen peroxide solution, react for 5-50 hours, then add water for further hydrolysis; more preferably after adding aqueous hydrogen peroxide solution, react for 10-40 hours, then add water for further hydrolysis. The present invention tracks and monitors the above-mentioned reaction process through TLC, and recommends a mixed solvent of cyclohexane:acetone (volume ratio)=5:5 as a developer.

进一步,本发明所述的泼尼松龙和酸性离子液体的投料质量比为1∶1~20,优选为1∶8~15,更优选1∶10。Further, the mass ratio of prednisolone and acidic ionic liquid according to the present invention is 1:1-20, preferably 1:8-15, more preferably 1:10.

进一步,本发明所述的泼尼松龙与过氧化氢的摩尔比为1∶1~10,优选1∶3~5。本发明对于使用的过氧化氢水溶液的浓度没有特别要求,比如质量浓度30~70%的过氧化氢水溶液都适用于本发明。Further, the molar ratio of prednisolone to hydrogen peroxide in the present invention is 1:1-10, preferably 1:3-5. The present invention has no special requirement on the concentration of the hydrogen peroxide aqueous solution used, for example, the hydrogen peroxide aqueous solution with a mass concentration of 30-70% is applicable to the present invention.

本发明对于反应过程中加入的用以进一步水解的水的用量也没有特别要求,本领域技术人员可以根据实际情况进行调整。本发明中一般加入泼尼松龙质量40~60倍的水进一步水解。The present invention has no special requirements on the amount of water added in the reaction process for further hydrolysis, and those skilled in the art can adjust it according to actual conditions. In the present invention, water with 40 to 60 times the mass of prednisolone is generally added for further hydrolysis.

本发明具体推荐所述的合成方法按照如下步骤进行:将泼尼松龙加到酸性离子液体中,在100~150℃下进行反应,TLC跟踪至原料点消失,冷却至室温,加入过氧化氢水溶液,在10~60℃下反应5~50h,再加入水进一步水解,TLC跟踪反应进程,反应结束后所得反应液经后处理得到所述的16α-羟基泼尼松龙产品;所述的泼尼松龙和酸性离子液体的投料质量比为1∶1~20;所述的泼尼松龙与过氧化氢的投料摩尔比为1∶1~10。The present invention specifically recommends that the synthetic method be carried out according to the following steps: adding prednisolone to the acidic ionic liquid, reacting at 100-150°C, tracking by TLC until the raw material point disappears, cooling to room temperature, adding hydrogen peroxide Aqueous solution, reacted at 10-60°C for 5-50h, then added water for further hydrolysis, TLC followed the reaction process, after the reaction, the reaction solution obtained was post-processed to obtain the 16α-hydroxyprednisolone product; the prednisolone The feeding mass ratio of nisolone and acidic ionic liquid is 1:1-20; the feeding molar ratio of prednisolone and hydrogen peroxide is 1:1-10.

所述的后处理采用如下步骤:反应液用甲苯萃取,取甲苯层,用蒸馏水洗涤,以无水硫酸镁干燥甲苯层,减压蒸除甲苯,得到16α-羟基泼尼松龙产品。甲苯萃取后所得萃余液可直接加入反应体系用于反应,重复使用3~5次后,用水洗涤,二氯甲烷萃取,干燥浓缩后又可重复使用。The post-treatment adopts the following steps: the reaction solution is extracted with toluene, the toluene layer is taken, washed with distilled water, dried with anhydrous magnesium sulfate, and the toluene is evaporated under reduced pressure to obtain the 16α-hydroxyprednisolone product. The raffinate obtained after toluene extraction can be directly added to the reaction system for reaction, and after repeated use for 3 to 5 times, it can be washed with water, extracted with dichloromethane, dried and concentrated, and then reused.

与现有技术相比,本发明所述的合成方法利用酸性离子液体既作为反应介质又作为催化剂的性质,通过改变反应时间和反应温度等工艺条件,实现了降低成本、节能减排的目的,适于工业化生产。具体而言,本发明技术易操作,产能高,效率好,三废少,后处理方便,离子液体可重复使用,是经济实用的绿色环保技术。Compared with the prior art, the synthesis method of the present invention utilizes the properties of the acidic ionic liquid as both the reaction medium and the catalyst, and by changing the process conditions such as reaction time and reaction temperature, the purposes of cost reduction, energy saving and emission reduction are achieved. Suitable for industrial production. Specifically, the technology of the present invention is easy to operate, high in production capacity, good in efficiency, less in three wastes, convenient in post-processing, and reusable in ionic liquids, and is an economical and practical green technology.

(四)具体实施方式 (4) Specific implementation methods

下面结合具体实施例对本发明进行进一步描述,但本发明的保护范围并不仅限于此。The present invention will be further described below in conjunction with specific examples, but the protection scope of the present invention is not limited thereto.

本发明实施例中所述的过氧化氢以质量浓度30%的过氧化氢水溶液的形式加入,实施例中的质量和物质的量均以过氧化氢本身计。The hydrogen peroxide described in the examples of the present invention is added in the form of an aqueous hydrogen peroxide solution with a mass concentration of 30%, and the quality and amount of substances in the examples are all calculated by hydrogen peroxide itself.

实施例1Example 1

将泼尼松龙(I)0.1g(2.77×10-4mol)和甲基丁基磺酸基咪唑硫酸氢盐酸性离子液体1g加入反应瓶中,保持温度在120℃,反应过程用TLC跟踪监测,以环己烷∶丙酮(体积比)=5∶5的混合溶剂作为展开剂,直至原料点消失。然后,冷却至室温,加入过氧化氢0.028g(8.31×10-4mol),在50℃下反应20小时,再加入5毫升水,薄层板(以环己烷∶丙酮(体积比)=5∶5的混合溶剂作为展开剂)跟踪反应结束后,加入用3×5mL甲苯萃取,合并萃取液,用3×5mL蒸馏水洗涤后,分出有机层,无水硫酸镁干燥后,减压蒸馏至恒重,得到如式(III)所示的16α-羟基泼尼松龙产品0.09g,收率为90%。Mp:238~241℃。H1NMRδ:0.98(s,3H),1.49(s,3H),4.24-4.68(dd,2H,J=20.1,Hz).4.50(d,1H,J=2.5Hz),5.08(d,1H,J=8.2Hz),6.03(s,3H),6.28(d,1H,9.3Hz),7.25(d,1H,J=10.1Hz)。Add 0.1 g of prednisolone (I) (2.77×10 -4 mol) and 1 g of methyl butyl sulfoimidazolium bisulfate acidic ionic liquid into the reaction flask, keep the temperature at 120 ° C, and track the reaction process with TLC For monitoring, a mixed solvent of cyclohexane:acetone (volume ratio)=5:5 was used as a developing solvent until the raw material point disappeared. Then, cool to room temperature, add hydrogen peroxide 0.028g (8.31 * 10 -4 mol), react at 50 ℃ for 20 hours, then add 5 milliliters of water, thin-layer plate (by cyclohexane: acetone (volume ratio) = 5:5 mixed solvent as developing agent) after tracking the reaction, add 3×5mL toluene for extraction, combine the extracts, wash with 3×5mL distilled water, separate the organic layer, dry over anhydrous magnesium sulfate, and distill under reduced pressure To constant weight, 0.09 g of 16α-hydroxyprednisolone product as shown in formula (III) was obtained, and the yield was 90%. Mp: 238-241°C. H 1 NMRδ: 0.98(s, 3H), 1.49(s, 3H), 4.24-4.68(dd, 2H, J=20.1, Hz). 4.50(d, 1H, J=2.5Hz), 5.08(d, 1H , J=8.2Hz), 6.03(s, 3H), 6.28(d, 1H, 9.3Hz), 7.25(d, 1H, J=10.1Hz).

实施例2Example 2

将泼尼松龙(I)0.1g(2.77×10-4mol)和甲基丁基磺酸基咪唑醋酸盐酸性离子液体1g加入反应瓶中,保持温度在150℃,反应过程用TLC跟踪监测,以环己烷∶丙酮(体积比)=5∶5的混合溶剂作为展开剂,直至原料点消失。然后,冷却至室温,加入过氧化氢0.009g(2.77×10-4mol),在50℃下反应10小时,再加入5毫升水,薄层板(以环己烷∶丙酮(体积比)=5∶5的混合溶剂作为展开剂)跟踪反应结束后,加入用3×5mL甲苯萃取,合并萃取液,用3×5mL蒸馏水洗涤后,分出有机层,无水硫酸镁干燥后,减压蒸馏至恒重,得到如式(III)所示的16α-羟基泼尼松龙产品0.08g,收率为80%。Add 0.1 g (2.77×10 -4 mol) of prednisolone (I) and 1 g of methyl butylsulfoimidazole acetate acidic ionic liquid into the reaction flask, keep the temperature at 150 ° C, and track and monitor the reaction process with TLC , using a mixed solvent of cyclohexane: acetone (volume ratio) = 5:5 as a developing solvent until the raw material point disappears. Then, cool to room temperature, add hydrogen peroxide 0.009g (2.77 * 10 -4 mol), react at 50 ℃ for 10 hours, then add 5 milliliters of water, thin-layer plate (by cyclohexane: acetone (volume ratio) = 5:5 mixed solvent as developing agent) after tracking the reaction, add 3×5mL toluene for extraction, combine the extracts, wash with 3×5mL distilled water, separate the organic layer, dry over anhydrous magnesium sulfate, and distill under reduced pressure To constant weight, 0.08 g of 16α-hydroxyprednisolone product as shown in formula (III) was obtained, and the yield was 80%.

实施例3Example 3

将泼尼松龙(I)0.1g(2.77×10-4mol)和甲基丁基磺酸基咪唑四氟硼酸盐酸性离子液体1g加入反应瓶中,保持温度在100℃,反应过程用TLC跟踪监测,以环己烷∶丙酮(体积比)=5∶5的混合溶剂作为展开剂,直至原料点消失。然后,冷却至室温,加入过氧化氢0.094g(2.77×10-3mol),在50℃下反应20小时,再加入5毫升水,薄层板(以环己烷∶丙酮(体积比)=5∶5的混合溶剂作为展开剂)跟踪反应结束后,加入用3×5mL甲苯萃取,合并萃取液,用3×5mL蒸馏水洗涤后,分出有机层,无水硫酸镁干燥后,减压蒸馏至恒重,得到如式(III)所示的16α-羟基泼尼松龙产品0.092g,收率为92%。Add 0.1 g of prednisolone (I) (2.77×10 -4 mol) and 1 g of methyl butylsulfoimidazolium tetrafluoroborate acidic ionic liquid into the reaction flask, keep the temperature at 100 ° C, and use TLC to monitor the reaction process Tracking and monitoring, using a mixed solvent of cyclohexane: acetone (volume ratio) = 5: 5 as a developing solvent until the raw material point disappears. Then, cool to room temperature, add hydrogen peroxide 0.094g (2.77 * 10 -3 mol), react at 50 ℃ for 20 hours, then add 5 milliliters of water, thin-layer plate (by cyclohexane: acetone (volume ratio) = 5:5 mixed solvent as developing agent) after tracking the reaction, add 3×5mL toluene for extraction, combine the extracts, wash with 3×5mL distilled water, separate the organic layer, dry over anhydrous magnesium sulfate, and distill under reduced pressure To constant weight, 0.092 g of 16α-hydroxyprednisolone product as shown in formula (III) was obtained, and the yield was 92%.

实施例4Example 4

将泼尼松龙(I)0.1g(2.77×10-4mol)和甲基丁基磺酸基咪唑硫酸氢盐酸性离子液体0.8g加入反应瓶中,保持温度在120℃,反应过程用TLC跟踪监测,以环己烷∶丙酮(体积比)=5∶5的混合溶剂作为展开剂,直至原料点消失。然后,冷却至室温,加入过氧化氢0.047g(13.85×10-4mol),在10℃下反应30小时,再加入5毫升水,薄层板(以环己烷∶丙酮(体积比)=5∶5的混合溶剂作为展开剂)跟踪反应结束后,加入用3×5mL甲苯萃取,合并萃取液,用3×5mL蒸馏水洗涤后,分出有机层,无水硫酸镁干燥后,减压蒸馏至恒重,得到如式(III)所示的16α-羟基泼尼松龙产品0.089g,收率为89%。Add 0.1 g (2.77×10 -4 mol) of prednisolone (I) and 0.8 g of methyl butylsulfoimidazolium bisulfate acidic ionic liquid into the reaction flask, keep the temperature at 120 °C, and use TLC to monitor the reaction process. Tracking and monitoring, using a mixed solvent of cyclohexane: acetone (volume ratio) = 5: 5 as a developing solvent until the raw material point disappears. Then, cool to room temperature, add hydrogen peroxide 0.047g (13.85 * 10 -4 mol), react at 10 ℃ for 30 hours, then add 5 milliliters of water, thin-layer plate (by cyclohexane: acetone (volume ratio) = 5:5 mixed solvent as developing agent) after tracking the reaction, add 3×5mL toluene for extraction, combine the extracts, wash with 3×5mL distilled water, separate the organic layer, dry over anhydrous magnesium sulfate, and distill under reduced pressure To constant weight, 0.089 g of 16α-hydroxyprednisolone product as shown in formula (III) was obtained, and the yield was 89%.

实施例5Example 5

将泼尼松龙(I)0.1g(2.77×10-4mol)和甲基丁基磺酸基咪唑硫酸氢盐酸性离子液体1.5g加入反应瓶中,保持温度在120℃,反应过程用TLC跟踪监测,以环己烷∶丙酮(体积比)=5∶5的混合溶剂作为展开剂,直至原料点消失。然后,冷却至室温,加入过氧化氢0.038g(11.08×10-4mol),在40℃下反应25小时,再加入5毫升水,薄层板(以环己烷∶丙酮(体积比)=5∶5的混合溶剂作为展开剂)跟踪反应结束后,加入用3×5mL甲苯萃取,合并萃取液,用3×5mL蒸馏水洗涤后,分出有机层,无水硫酸镁干燥后,减压蒸馏至恒重,得到如式(III)所示的16α-羟基泼尼松龙产品0.09g,收率为90%。Add 0.1 g (2.77×10 -4 mol) of prednisolone (I) and 1.5 g of methyl butylsulfoimidazolium bisulfate acidic ionic liquid into the reaction flask, keep the temperature at 120°C, and use TLC to monitor the reaction process. Tracking and monitoring, using a mixed solvent of cyclohexane:acetone (volume ratio)=5:5 as a developing solvent until the raw material point disappears. Then, cool to room temperature, add hydrogen peroxide 0.038g (11.08 * 10 -4 mol), react at 40 ℃ for 25 hours, then add 5 milliliters of water, thin-layer plate (by cyclohexane: acetone (volume ratio) = 5:5 mixed solvent as developing agent) after tracking the reaction, add 3×5mL toluene for extraction, combine the extracts, wash with 3×5mL distilled water, separate the organic layer, dry over anhydrous magnesium sulfate, and distill under reduced pressure To constant weight, 0.09 g of 16α-hydroxyprednisolone product as shown in formula (III) was obtained, and the yield was 90%.

Claims (10)

1.一种结构如式(III)所示的16α-羟基泼尼松龙的合成方法,包括如下步骤:以结构如式(I)所示的泼尼松龙为原料,在结构如式(II)所示的酸性离子液体中,先进行脱水反应生成双键,然后加入过氧化氢水溶液进行反应,充分反应后加入水进一步水解,最后得到所述的16α-羟基泼尼松龙;1. a kind of synthetic method of the 16α-hydroxy prednisolone shown in formula (III) of structure, comprises the steps: be raw material with the prednisolone shown in formula (I) with structure, in structure such as formula ( In the acidic ionic liquid shown in II), first carry out dehydration reaction to generate double bonds, then add hydrogen peroxide aqueous solution to react, add water after fully reacting and further hydrolyze, finally obtain described 16α-hydroxy prednisolone;
Figure FDA0000130769260000011
Figure FDA0000130769260000011
式(II)中,R为C1~C10的取代烷基,所述的取代烷基的取代基为磺酸基或羧基,L为HSO4、CH3COO、BF4、PF6或CF3SO3;或者R为C1~C10的烷基,L为HSO4或CF3SO3In formula (II), R is a C1-C10 substituted alkyl group, the substituent of the substituted alkyl group is a sulfonic acid group or a carboxyl group, and L is HSO 4 , CH 3 COO, BF 4 , PF 6 or CF 3 SO 3 ; or R is a C1-C10 alkyl group, and L is HSO 4 or CF 3 SO 3 .
2.如权利要求1所述的16α-羟基泼尼松龙的合成方法,其特征在于所述的式(II)所示的酸性离子液体,R为C1~C10的取代烷基,所述的取代烷基的取代基为磺酸基,L为HSO4、CH3COO或BF42. the synthetic method of 16α-hydroxyprednisolone as claimed in claim 1 is characterized in that the acidic ionic liquid shown in described formula (II), R is the substituted alkyl of C1~C10, described The substituent of the substituted alkyl group is a sulfonic acid group, and L is HSO 4 , CH 3 COO or BF 4 . 3.如权利要求1或2所述的16α-羟基泼尼松龙的合成方法,其特征在于所述的脱水反应在100~150℃的温度条件下进行。3. the synthetic method of 16α-hydroxyprednisolone as claimed in claim 1 or 2 is characterized in that described dehydration reaction is carried out under the temperature condition of 100~150 ℃. 4.如权利要求3所述的16α-羟基泼尼松龙的合成方法,其特征在于所述的脱水反应在110~130℃的温度条件下进行。4. the synthetic method of 16α-hydroxyprednisolone as claimed in claim 3 is characterized in that described dehydration reaction is carried out under the temperature condition of 110~130 ℃. 5.如权利要求1或2所述的16α-羟基泼尼松龙的合成方法,其特征在于:加入过氧化氢水溶液后于10~60℃进行反应,充分反应后再加入水于10~60℃进一步水解。5. The synthetic method of 16α-hydroxyprednisolone as claimed in claim 1 or 2, is characterized in that: react at 10~60 ℃ after adding hydrogen peroxide aqueous solution, add water again at 10~60 ℃ after fully reacting °C for further hydrolysis. 6.如权利要求2所述的16α-羟基泼尼松龙的合成方法,其特征在于:加入过氧化氢水溶液后于10~60℃反应5~50h,再加入水进一步水解。。6. The synthetic method of 16α-hydroxyprednisolone as claimed in claim 2, characterized in that: after adding hydrogen peroxide aqueous solution, react at 10~60°C for 5~50h, then add water for further hydrolysis. . 7.如权利要求1或2所述的16α-羟基泼尼松龙的合成方法,其特征在于所述的泼尼松龙和酸性离子液体的投料质量比为1∶1~20。7. the synthetic method of 16α-hydroxy prednisolone as claimed in claim 1 or 2 is characterized in that the mass ratio of feeding intake of described prednisolone and acidic ionic liquid is 1: 1~20. 8.如权利要求1或2所述的16α-羟基泼尼松龙的合成方法,其特征在于所述的泼尼松龙与过氧化氢的投料摩尔比为1∶1~10。8. the synthetic method of 16α-hydroxy prednisolone as claimed in claim 1 or 2 is characterized in that the molar ratio of described prednisolone and hydrogen peroxide is 1: 1~10. 9.如权利要求1或2所述的16α-羟基泼尼松龙的合成方法,其特征在于所述的合成方法按照如下步骤进行:将泼尼松龙加到酸性离子液体中,在100~150℃下进行反应,TLC跟踪至原料点消失,冷却至室温,加入过氧化氢水溶液,在10~60℃下反应5~50h,然后加入水继续反应,TLC跟踪反应进程,反应结束后所得反应液经后处理得到所述的16α-羟基泼尼松龙产品;所述的泼尼松龙和酸性离子液体的投料质量比为1∶1~20;所述的泼尼松龙与过氧化氢的投料摩尔比为1∶1~10。9. the synthetic method of 16α-hydroxy prednisolone as claimed in claim 1 or 2 is characterized in that described synthetic method is carried out according to the following steps: prednisolone is added in the acidic ionic liquid, at 100 ~ Carry out the reaction at 150°C, follow TLC until the raw material point disappears, cool to room temperature, add aqueous hydrogen peroxide solution, react at 10-60°C for 5-50 hours, then add water to continue the reaction, track the reaction process by TLC, and obtain the reaction after the end of the reaction The liquid obtains the described 16α-hydroxy prednisolone product through aftertreatment; The mass ratio of the feed intake of the described prednisolone and the acidic ionic liquid is 1: 1~20; The described prednisolone and hydrogen peroxide The molar ratio of feed is 1:1~10. 10.如权利要求9所述的16α-羟基泼尼松龙的合成方法,其特征在于所述的后处理采用如下步骤:反应液用甲苯萃取,取甲苯层,用蒸馏水洗涤,以无水硫酸镁干燥甲苯层,减压蒸干溶剂,得到16α-羟基泼尼松龙产品。10. the synthetic method of 16α-hydroxyprednisolone as claimed in claim 9 is characterized in that described aftertreatment adopts the following steps: reaction solution extracts with toluene, gets the toluene layer, washes with distilled water, with anhydrous sulfuric acid The toluene layer was dried with magnesium, and the solvent was evaporated to dryness under reduced pressure to obtain the 16α-hydroxyprednisolone product.
CN2010102058780A 2010-06-22 2010-06-22 Synthetic method of 16alpha-hydroxy prednisonlone Expired - Fee Related CN101875681B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2010102058780A CN101875681B (en) 2010-06-22 2010-06-22 Synthetic method of 16alpha-hydroxy prednisonlone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2010102058780A CN101875681B (en) 2010-06-22 2010-06-22 Synthetic method of 16alpha-hydroxy prednisonlone

Publications (2)

Publication Number Publication Date
CN101875681A CN101875681A (en) 2010-11-03
CN101875681B true CN101875681B (en) 2012-08-08

Family

ID=43018373

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010102058780A Expired - Fee Related CN101875681B (en) 2010-06-22 2010-06-22 Synthetic method of 16alpha-hydroxy prednisonlone

Country Status (1)

Country Link
CN (1) CN101875681B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102850423B (en) * 2012-09-26 2014-07-09 仙居县力天化工有限公司 Synthesis method of 16alpha-hydroxy prednisolone
CN104788469B (en) * 2015-04-14 2017-03-01 临海市利民化工有限公司 A kind of preparation method of Clopidogrel Bisulfate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3109459A1 (en) * 1981-03-09 1982-09-23 Schering Ag, 1000 Berlin Und 4619 Bergkamen (DELTA) (UP ARROW) 9 (UP ARROW) (UP ARROW) ((UP ARROW) (UP ARROW) 1 (UP ARROW) (UP ARROW) 1 (UP ARROW) (UP ARROW)) (UP ARROW) - AND (DELTA) (UP ARROW) 1 (UP ARROW) (UP ARROW) 6 (UP ARROW) -21-CHLORINE-20-KETO STEROIDS OF THE PREGNAN AND D-HOMO-PREGNAN SERIES, METHODS FOR THEIR PREPARATION AND USE AS AN INTERMEDIATE PRODUCT FOR THE SYNTHESIS OF HIGHLY EFFECTIVE CORTICOIDS
WO2007054974A2 (en) * 2005-09-28 2007-05-18 Arch Pharmalab Limited A green chemistry process for the preparation of pregnadiene esters
CN101279997B (en) * 2008-05-29 2011-08-24 鲁南制药集团股份有限公司 Novel preparation of budesonide

Also Published As

Publication number Publication date
CN101875681A (en) 2010-11-03

Similar Documents

Publication Publication Date Title
CN101830821B (en) Chemical synthesis method of N-alcoxyloxalyl alanine ester
CN101812039A (en) Method for generating 5-hydroxymethylfurfural by using ionic liquid catalysis
CN103467435A (en) Method for preparing glycerol carbonate
CN114380965A (en) Polybenzimidazole ionic covalent organic framework material BM-S and preparation method and application thereof
CN105618139B (en) A kind of ligocellulose degradation's method based on molybdenum multi-metal oxygen hydrochlorate
CN103864615A (en) Method for preparing ethyl trifluoroacetate through continuous non-catalytic method
CN101875681B (en) Synthetic method of 16alpha-hydroxy prednisonlone
CN103553925B (en) Process for synthesizing nitrocyclohexane by liquid phase nitration
CN105732444A (en) Synthesis method of belinostat
CN104086392A (en) Catalytic synthesis method for biphenylacetic acid
CN102329233A (en) Method for catalytically synthesizing diisooctyl terephthalate under action of ionic liquid
CN103951561B (en) A kind of method for preparing L-menthol glyoxylate monohydrate by heteropolyacid catalysis
CN103880617B (en) A kind of propargyl alcohol aoxidizes the method for acetylenic ketone processed
CN104307569A (en) Heteropoly acid type ionic liquid catalyst as well as preparation and application thereof
CN102718672B (en) Synthetic method of p-hydroxyphenylglycine methyl ester
CN101717428B (en) Method for synthesizing budesonide
CN101857627B (en) Synthesis method for ciclesonide
CN103030552B (en) Method for one-time synthesis of 2-phenylpropionic acid by strawberry aldehyde
CN104030925A (en) Method for catalytically synthesizing mononitrochlorobenzene
CN102675052B (en) Method for preparing dihydroxybenzene through phenol hydroxylation reaction
CN102942548A (en) Delta-dodecalactone synthesis method
CN102850423B (en) Synthesis method of 16alpha-hydroxy prednisolone
CN116239496A (en) Method for continuously preparing heptafluoroisobutyronitrile
CN101381297A (en) A method for separating octanoic acid from octadecanoic acid mixture
CN106117085A (en) A kind of method synthesizing N (ethoxymeyhylene) aniline for catalyst with styrene Styrene Sulfonic Acid Copolymer microsphere

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20201214

Address after: 251909 East Chengkou Town, Wudi County, Binzhou City, Shandong Province

Patentee after: Wudi Xinyue Chemical Group Co.,Ltd.

Address before: Hangzhou City, Zhejiang province 310014 City Zhaohui District Six

Patentee before: ZHEJIANG University OF TECHNOLOGY

TR01 Transfer of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20120808

CF01 Termination of patent right due to non-payment of annual fee